Amaç: Ortalama trombosit hacminin (OTH), inflamatuar hastalıkların da dâhil olduğu birçok kronik hastalıkta belirteç olarak kullanılabileceği gösterilmiştir. Çalışmamızda, Ailesel Akdeniz Ateşi (AAA) olan çocuklarda; hastalık şiddeti, genetik mutasyon türü, atak/ataksız dönemlerin, OTH düzeyleri ile ilişkisini incelemeyi planladık. Gereç ve Yöntemler: Çalışmaya, Tel-Hashomer tanı kriterlerine göre AAA tanısı almış 109 çocuk dâhil edildi. Hastalar, Pras skorlama sistemine göre sınıflandırıldı. Hastaların demografik özellikleri, genetik tarama sonuçları, başvuru şikâyetleri ile tam kan sayımı parametreleri, OTH düzeyleri, biyokimyasal testleri, proteinüri miktarları, fibrinojen, eritrosit sedimantasyon hızı, C-reaktif protein değerleri, ataklı ve ataksız dönemlerine göre ayrı ayrı kaydedildi. Bulgular: Çalışmamıza, toplam 109 (kız/erkek: 58/51) hasta dâhil edildi. Hastaların yaş ortalaması, 9,22±4,28 (minimum-maksimum: 1,1-17,9) yıl idi. Hastaların genetik sonuçları ile hastalık skoru arasında anlamlı bir ilişki gösterilemedi. Artriti olan hastaların, artriti olmayanlara göre semptom şiddet skorları anlamlı şekilde yüksekti (p<0,001). OTH, atak döneminde ataksız döneme göre anlamlı şekilde düşüktü (7,92±0,19; 8,19±0,27 fL, p=0,001). Hastalık ağırlık şiddet skoru en yüksek olanlarda, en düşük OTH düzeyi gösterildi (p=0,048). Atak döneminde proteinürisi olan hastaların OTH düzeyleri, olmayanlara göre anlamlı düşüktü (p=0,03). Sonuç: AAA hastalarında; kolay, ucuz ve hızlı bir yöntem olan OTH ölçümünün, atak ve hastalık şiddetini belirlemede destekleyici bir parametre olabileceğini düşünmekteyiz.
Anahtar Kelimeler: Ailevi Akdeniz Ateşi; ortalama trombosit hacmi
Objective: It has been shown that mean platelet volume (MPV) can be used as a marker in many chronic diseases, including inflammatory diseases. In our study, we aimed to examine the relationship between disease severity, genetic mutation, attack/no-attack episodes with MPV levels in children with Familial Mediterranean Fever (FMF). Material and Methods: 109 children diagnosed with FMF according to Tel-Hashomer criteria were included in the study. The patients were classified according to the Pras scoring system. Patients demographic characteristics, genetic screening results, admission complaints and complete blood count parameters, MPV levels, biochemical tests, proteinuria amounts, fibrinogen, erythrocyte sedimentation rate, C-reactive protein values were recorded separately according to their attack/without attack periods. Results: A total of 109 (female/male: 58/51) patients were included in our study. The mean age of the patients was 9.22±4.28 (minimum-maximum: 1.1-17.9) years. A significant relationship between the genetic results of the patients and the disease score could not be shown. Symptom severity scores of patients with arthritis were significantly higher than those without arthritis (p<0.001). MPV was significantly lower in the attack period compared to the attack-free period (7.92±0.19; 8.19±0.27 fL, p=0.001). Those with the highest disease severity score showed the lowest MPV level (p=0.048). MPV levels of patients with proteinuria during the attack period were lower than those without (p=0.03). Conclusion: We think that MPV measurement, which is an easy, inexpensive and fast method, can be a supportive parameter in determining the severity of attacks and disease of FMF patients.
Keywords: Familial Mediterranean Fever; mean platelet volume
- Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol. 2017; 36(8):1707-13. [Crossref] [PubMed]
- Baskin E, Saatci U. Microalbuminuria in the course of familial Mediterranean fever. Nep hrol Dial Transplant. 2004;19(10):2678. [Crossref] [PubMed]
- Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med. 2007;65(9):318-24. [PubMed]
- Migita K, Asano T, Sato S, Koga T, Fujita Y, Kawakami A. Familial Mediterranean fever: overview of pathogenesis, clinical features and management. Immunol Med. 2018;41(2): 55-61. [Crossref] [PubMed]
- Erer B, Demirkaya E, Ozen S, Kallinich T. What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review. Rheumatol Int. 2016;36(4): 483-7. [Crossref] [PubMed]
- Yorulmaz A, Akbulut H, Taş SA, Tıraş M, Yahya İ, Peru H. Evaluation of hematological parameters in children with FMF. Clin Rheumatol. 2019;38(3):701-7. [Crossref] [PubMed]
- Korkmaz C, Ozdogan H, Kasapçopur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis. 2002;61(1):79-81. [Crossref] [PubMed] [PMC]
- Bakan A, Oral A, Alışır Ecder S, Şaşak Kuzgun G, Elçioğlu ÖC, Demirci R, et al. Assessment of mean platelet volume in patients with AA amyloidosis and AA amyloidosis secondary to familial Mediterranean fever: a retrospective chart - review study. Med Sci Monit. 2019;25:3854-9. [PubMed] [PMC]
- Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators Inflamm. 2019; 2019:9213074. [Crossref] [PubMed] [PMC]
- Schmoeller D, Picarelli MM, Paz Munhoz T, Poli de Figueiredo CE, Staub HL. Mean platelet volume and immature platelet fraction in autoimmune disorders. Front Med (Lausanne). 2017;4:146. [Crossref] [PubMed] [PMC]
- Sakallı H, Kal O. Mean platelet volume as a potential predictor of proteinuria and amyloidosis in familial Mediterranean fever. Clin Rheumatol.2013;32(8):1185-90. [Crossref] [PubMed]
- Sahin S, Senel S, Ataseven H, Yalcin I. Does mean platelet volume influence the attack or attack-free period in the patients with Familial Mediterranean fever? Platelets. 2013;24(4): 320-3. [Crossref] [PubMed]
- Makay B, Türkyilmaz Z, Unsal E. Mean platelet volume in children with familial Mediterranean fever. Clin Rheumatol. 2009; 28(8):975-8. [Crossref] [PubMed]
- Coban E, Adanir H. Platelet activation in patients with Familial Mediterranean Fever. Platelets. 2008;19(6):405-8. [Crossref] [PubMed]
- Doğruel D, Kışla Ekinci RM, Balcı S, Yılmaz M, Altıntaş DU. Ailevi Akdeniz ateşi olan çocuklarda ortalama trombosit hacminin klinik önemi [Clinical importance of mean platelet volume in children with family Mediterranean fever]. ACU Sağlık Bil Derg. 2019;10(4):589-92. [Crossref]
- Arıca S, Ozer C, Arıca V, Karakuş A, Celik T, Güneşaçar R. Evaluation of the mean platelet volume in children with familial Mediterranean fever. Rheumatol Int. 2012;32(11):3559-63. [Crossref] [PubMed]
- Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1):47-58. [Crossref] [PubMed]
- Inal A, Yilmaz M, Kendirli SG, Altintas DU, Karakoc GB. The clinical and genetical features of 124 children with Familial Mediterranean fever: experience of a single tertiary center. Rheumatol Int. 2009;29(11):1279-85. [Crossref] [PubMed]
- Coşkun S, Kurtgöz S, Keskin E, Sönmez F, Bozkurt G. Frequency of mutations in Mediterranean fever gene, with gender and genotype-phenotype correlations in a Turkish popu lation. J Genet. 2015;94(4):629-35. [Crossref] [PubMed]
- Yalçinkaya F, Cakar N, Misirlioğlu M, Tümer N, Akar N, Tekin M, et al. Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology (Oxford). 2000;39(1):67-72. Erratum in: Rheumatology (Oxford) 2000;39(10):1170. [Crossref] [PubMed]
- Duşunsel R, Dursun I, Gündüz Z, Poyrazoğlu MH, Gürgöze MK, Dundar M. Genotype-phenotype correlation in children with familial Mediterranean fever in a Turkish population. Pediatr Int. 2008;50(2):208-12. [Crossref] [PubMed]
- Ozturk C, Halicioglu O, Coker I, Gulez N, Sutçuoglu S, Karaca N, et al. Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, Turkey. Clin Rheumatol. 2012;31(3):493-501. [Crossref] [PubMed]
- Barut K, Sinoplu AB, Yucel G, Pamuk G, Adrovic A, Sahin S, et al. Familial Mediterranean Fever in childhood: a single center experience. Pediatric Rheumatology. 2015; 13(1):1-2. [Crossref] [PMC]
- Ece A, Çakmak E, Uluca Ü, Kelekçi S, Yolbaş İ, Güneş A, et al. The MEFV mutations and their clinical correlations in children with familial Mediterranean fever in southeast Turkey. Rheumatol Int. 2014;34(2):207-12. [Crossref] [PubMed]
- Cazeneuve C, Sarkisian T, Pêcheux C, Dervichian M, Nédelec B, Reinert P, et al. MEFV-Gene analysis in armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet. 1999;65(1): 88-97. [Crossref] [PubMed] [PMC]
- Soylemezoglu O, Kandur Y, Duzova A, Ozkaya O, Kasapcopur O, Baskin E, et al. Familial Mediterranean fever with a single MEFV mutation: comparison of rare and common mutations in a Turkish paediatric cohort. Clin Exp Rheumatol. 2015;33(6 Suppl 94):S152-5. [PubMed]
.: İşlem Listesi